Product Wiki · Recalls · Health Canada — Medical Devices

Advia Centaur / XP / XPT — recall 56844

Health Canada — Medical Devices · Canada · 2017-04-13 · Type III

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
56844
Date of alert
2017-04-13
Country / jurisdiction
Canada
Risk level
Type III
Risk type
recall
Product category
Medical devices
Product type
Medical devices
Notice status
Archived by the issuing authority — kept for reference
Reported risk: Potential for the Advia Centaur Syphilis assay to interfere with the Br (Ca 27.29) assay on the Advia Centaur Systems. This interference only occurs when the Syphilis assay immediately precedes the Br assay on the Advia Centaur, Advia Centaur XP or Advia Centaur XPT systems. The Advia Centaur CP system is not impacted. The issue affects all current and future lots of Advia Centaur Systems Br reagents until a solution is implemented.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/advia-centaur-xp-xpt

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.